References
- Alberti KGMN, Zimmet P, Shaw J. International diabetes federation: a consensus on type 2 diabetes prevention. Diabet Med 2007;24(5):451-63
- World Health Organization. Available from: http://apps.who.int/infobase/report.aspx?rid=112&ind=DIA [Last accessed 27 Feb 2014]
- The North American Menopause Society. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause 2012;19(3):257-71
- Santen RJ, Allred DC, Ardoin SP, et al. Endocrine Society. Postmenopausal hormone therapy. An Endocrine Society Scientific Statement. J clin Endocrinol Metab 2010;95(7 Suppl 1):3-71
- Sturdee DW, Pines A. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14(3):302-20
- The North American Menopause Society (NAMS). Estrogen and progestogen use in postmenopausal women: 2010. Position statement of The North American Menopause Society. Menopause 2010;17(2):242-55
- Monterrosa-Castro A, Blümel JE, Portela-Buelvas K, et al. Type II diabetes mellitus and menopause: a multinational study. Climacteric 2013;16:663-72
- Castelo-Branco C, Blümel JE, Calle A, et al. Age at menopause in Latin American. Menopause 2006;13(4):706-12
- De Villiers TJ, Gass M, Haines C, et al. Global Consensus statement of Menopausal Hormone Therapy. Climacteric 2013;16:203-4
- Gold E. Factors Associated with age at natural menopause in Multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-74
- Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004;364:875-82
- Cooper G, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol 1998;8:229-35
- Bromberger JT, Matthews KA, Kuller LH, et al. Prospective study of the determinants of age at menopause. Am J Epidemiol 1997;145:124-33
- Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Available from: www.hindawi.com/journals/bmri/2014/757461/Biomed Res Int 2014
- Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women’s Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-33
- Beral V, Banks E, Reeves G. Evidence from randomized trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942-4
- Anderson G, Limacher M, Assaf A, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy, the women’s health initiative randomized Controlled trial. JAMA 2004;291(14):1701-12
- Mascarenhas-Melo F, Marado D, Palabra F, et al. Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovasc Diabetol 2013;12:61